Enhanced therapeutic vaccine platform achieves 2 proof-of-concepts in veterinary medical use

(University of Zurich) Chronical allergic diseases of dogs and horses can now be treated with an innovative vaccine. It was developed by an international research team led by he University of Bern and in cooperation with the University of Zurich, together with private enterprise companies. The findings obtained in horses and dogs could lead to similar therapeutic vaccines for humans.